Search

everythinglearnresearchcommunity

for

Search:↓

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Dexpanthenol improves hair growth and satisfaction in women without side effects.

Men with hair loss may lack zinc, copper, and vitamin D; supplements could help.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Most people in the surveyed area experience hair loss, but they are not aware of the role of diet, iron, hormones, genetics, and possibly water quality in causing it.

Ayurvedic remedies may boost immunity and balance in cancer treatment but need more research.

The best mix for a hair loss treatment cream is 10% Sophora japonica tincture and 5% Serenoa repens extract.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Using finasteride with TIP extends time off period for prostate cancer patients.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.